Neural Mechanisms and Predictors of an Ultra-Brief Suicide Prevention Strategy

NCT ID: NCT05275101

Last Updated: 2026-02-05

Basic Information

• Recruitment Status: ACTIVE_NOT_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 191 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2021-07-28
• Study Completion Date: 2026-04-01

Brief Summary

The current study is a clinical trial, meaning a research study in which human subjects are prospectively assigned to one or more interventions to evaluate the effects of those interventions on health-related behavioral outcomes. Specifically, male and female adults with current suicidal intent will be randomly assigned to receive either a 1-hour session of crisis response planning (CRP) or a 1-hour session of standard crisis risk management (Treatment as Usual). The effects of both conditions on changes in emotion regulation, behavioral inhibition, stress reactivity, and suicide risk will be evaluated post-intervention and at six-month follow-up. Additional assessments of changes in mood and suicidality will be collected daily during the first 10-days following intervention, and then monthly for a duration of six months. A cohort of healthy controls is included in the study but are not randomized to either treatment condition. The investigators hypothesize the following: 1) A single session of CRP will acutely change suicide risk and 2) Individuals who receive CRP will show sustained improvements in measures of suicidality when compared to individuals who received the Treatment as Usual intervention.

Conditions

Suicide

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: BASIC_SCIENCE
• Blinding Strategy: DOUBLE

Study Groups

Control

Individuals who have not experienced suicidal ideation will not complete a suicide intervention.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Crisis Response Planning (CRP)

The crisis response planning (CRP) session will last between 30 minutes to 1-hour. It will occur face-to-face with a trained study therapist. The CRP session involves the following standard suicide intervention strategies: supportive listening, provision of crisis resources, and referral to a mental health professional (if not already established). The CRP active component involves a collaborative process in which the therapist invites the patient to share the events, symptoms, and contextual factors leading up to and surrounding the participant's suicidal crisis. Next, the patient and therapist identify the patient's personal warning signs for an emotional crisis, self-management coping skills, patient's reasons for living, and sources of social support. These components are written, by the patient, on an index card. The index card serves as a concrete reference for patients in the real-world.

Group Type: EXPERIMENTAL

Crisis Response Planning

Intervention Type: BEHAVIORAL

Individuals complete an experimental collaborative suicide intervention.

Crisis Risk Counseling

The crisis risk counseling session will last between 30 minutes to 1-hour. It will occur face-to-face with a trained study therapist. It will include the following standard suicide intervention strategies: supportive listening, provision of crisis resources, and referral to a mental health professional (if not already established). The therapist will conduct a semi-structured suicide risk assessment interview, after which subjects will complete a self-guided safety plan worksheet. The worksheet takes approximately 10-minutes to complete and will be done independently.

Group Type: ACTIVE_COMPARATOR

Crisis Risk Counseling

Intervention Type: BEHAVIORAL

Individuals complete a standard crisis risk management intervention.

Interventions

Crisis Response Planning

Individuals complete an experimental collaborative suicide intervention.

Intervention Type: BEHAVIORAL

Crisis Risk Counseling

Individuals complete a standard crisis risk management intervention.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Generally medically and neurologically healthy
• Age 18 years or older at the time of consent
• Willing and able to give informed consent
• Individuals in the acutely suicidal group: endorse current suicide intent as indicated by a total score of 5 or greater on the Beck's Scale for Suicidal Ideation.

Exclusion Criteria

• Medical or neurologic condition or neurocognitive dysfunction that would interfere with the study
• Current or past manic/hypomanic episode, schizophrenia, or psychotic symptoms
• Deafness in either ear
• Currently pregnant or trying to become pregnant
• Electroconvulsive therapy (ECT) within the past 6 months
• Current moderate to severe substance use disorder
• Lack of fluency in English
• Positive alcohol breathalyzer test and/or acute drug intoxication the day of the fMRI scans
• Unwilling or unable to sign the informed consent document
• Under 18 years old at the time of enrollment
• Traumatic brain injury from a suicide attempt or another event
• Presence of ferrous-containing metals within the body
• Inability to tolerate small, enclosed spaces without significant anxiety
• Individuals enrolled as controls: no lifetime history of any DSM-5 disorder
• Individuals enrolled as controls: no lifetime history of suicide ideation or intent

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Ohio State University

OTHER

Sponsor Role: lead

Responsible Party

Stephanie M Gorka, PhD

Associate Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Stephanie Gorka, PhD

Role: PRINCIPAL_INVESTIGATOR

Ohio State University

Locations

Ohio State University

Columbus, Ohio, United States

Countries

United States

Other Identifiers

2021H0039

Identifier Type: -

Identifier Source: org_study_id